Formulation and optimization of temozolomide nanoparticles by 3 factor 2 level factorial design
1Pharmaceutics Research Laboratory; Department of Pharmaceutics; Adina Institute of Pharmaceutical Sciences; Sagar, India.
Biomatter
|May 31, 2013
Summary
This study optimized temozolomide nanoparticle preparation using a 3(4) factorial design. Key variables influencing drug entrapment and particle size were identified for both non-PEGylated and PEGylated nanoparticles.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Nanotechnology
Background:
- Nanoparticles offer promising drug delivery systems for cancer therapeutics.
- Temozolomide is a key chemotherapeutic agent for brain tumors.
- Optimizing nanoparticle formulation is crucial for effective drug delivery and therapeutic outcomes.
Purpose of the Study:
- To investigate the combined influence of independent variables on temozolomide-loaded nanoparticle preparation.
- To optimize the emulsification solvent evaporation method for both non-PEGylated and PEGylated nanoparticles.
- To establish a predictive model for nanoparticle characteristics.
Main Methods:
- Utilized a 3(4) factorial design with 4 factors (drug concentration, PLGA/PEG-PLGA concentration, PVA concentration, sonication time) at 3 levels.
- Emulsification solvent evaporation method was employed for nanoparticle preparation.
- Analyzed percentage drug entrapment (PDE) and particle size (PS) using polynomial quadratic models and contour plots.
Main Results:
- Preliminary trials showed increased drug entrapment with drug concentration up to 5 mg.
- Further increases in drug concentration to 7.5 mg did not significantly affect drug entrapment or particle size.
- Contour plots were generated to visualize the impact of formulation variables on PDE and PS.
Conclusions:
- The 3(4) factorial design effectively modeled the preparation of temozolomide nanoparticles.
- Identified critical formulation parameters for controlling drug entrapment and particle size.
- The study provides a basis for optimizing temozolomide nanoparticle formulations for enhanced drug delivery.
Related Concept Videos
01:28Methods of Medium Optimization
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:23Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...